U.S. Preclinical Imaging Market Size & Outlook, 2023-2030
U.S. preclinical imaging market, 2018-2030 (US$M)
Related Markets
U.S. preclinical imaging market highlights
- The U.S. preclinical imaging market generated a revenue of USD 1,135.1 million in 2023 and is expected to reach USD 1,613.9 million by 2030.
- The U.S. market is expected to grow at a CAGR of 5.2% from 2024 to 2030.
- In terms of segment, optical was the largest revenue generating product in 2023.
- Multi Modal is the most lucrative product segment registering the fastest growth during the forecast period.
Preclinical imaging market data book summary
| Market revenue in 2023 | USD 1,135.1 million |
| Market revenue in 2030 | USD 1,613.9 million |
| Growth rate | 5.2% (CAGR from 2023 to 2030) |
| Largest segment | Optical |
| Fastest growing segment | Multi Modal |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CT, MRI, PET/SPECT, Multi Modal, Optical, Ultrasound, Photoacoustic, Reagents, Services |
| Key market players worldwide | Bruker Corp, Siemens AG, GE Aerospace, PerkinElmer, FUJIFILM Holdings Corp, Agilent Technologies, Rigaku, TriFoil Imaging, Mediso Medical Imaging Systems, MR Solutions |
Other key industry trends
- In terms of revenue, U.S. accounted for 26.3% of the global preclinical imaging market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. preclinical imaging market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 1,613.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Preclinical Imaging Market Scope
Preclinical Imaging Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. preclinical imaging market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to preclinical imaging market will help companies and investors design strategic landscapes.
Optical was the largest segment with a revenue share of 13.32% in 2023. Horizon Databook has segmented the U.S. preclinical imaging market based on ct, mri, pet/spect, multi modal, optical, ultrasound, photoacoustic, reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. accounted for a major revenue share of the preclinical imaging market in 2022. Some factors responsible for its dominance are aging demographic, advancing technologies, changing patient care strategies, and evolving epidemiological patterns. In addition, government agencies in the U.S. pay for a large portion of clinical trials on treatments of cancer.
The National Cancer Institute funds numerous clinical trials. Cancer cooperative groups, such as the National Surgical Adjuvant Breast & Bowel Project, are networks of preclinical centers and doctors in the U.S. that concentrate on a specific aspect or type of cancer.
The cancer cooperative groups also pay for clinical trials. This is expected to boost the market during the forecast period. The market for in vivo imaging systems in preclinical research is experiencing rapid growth, driven in part by the rising number of Clinical Research Organizations (CROs) and pharmaceutical companies.
Reasons to subscribe to U.S. preclinical imaging market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. preclinical imaging market databook
-
Our clientele includes a mix of preclinical imaging market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. preclinical imaging market , including forecasts for subscribers. This country databook contains high-level insights into U.S. preclinical imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. preclinical imaging market size, by product, 2018-2030 (US$M)
U.S. Preclinical Imaging Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
